ArticleAmerican journal of cancer research2019

Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations.

Junyoung Choi et al.PubMed ↗Full text ↗

No numbers read from the abstract.